Ownership history in Qube Research & Technologies Ltd · 8 quarters on record
This page tracks every 13F SEC filing in which Qube Research & Technologies Ltd reported a position in TSCAN THERAPEUTICS INC (TCRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 27,675 | -40,611 | -59.5% | 0.00% | $50K | $1.82 |
| 2025 Q2 | ADDED | 68,286 | +53,778 | +370.7% | 0.00% | $99K | $1.45 |
| 2024 Q4 | REDUCED | 14,508 | -40,056 | -73.4% | 0.00% | $44K | $3.04 |
| 2024 Q3 | REDUCED | 54,564 | -23,821 | -30.4% | 0.00% | $272K | $4.98 |
| 2024 Q2 | REDUCED | 78,385 | -65,151 | -45.4% | 0.00% | $459K | $5.85 |
| 2024 Q1 | ADDED | 143,536 | +63,547 | +79.4% | 0.00% | $1.1M | $7.94 |
| 2023 Q4 | ADDED | 79,989 | +77,579 | +3219.0% | 0.00% | $466K | $5.83 |
| 2023 Q3 | INITIATED | 2,410 | — | — | 0.00% | $6K | — |
As of 2025 Q4 — sorted by position size